Wouter Verhesen
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Viral Infections and Immunology Research
- Cardiac Fibrosis and Remodeling
Papers in
-
- Viral Infections and Immunology Research 4
- Cardiac Fibrosis and Remodeling 3
-
- RNA Research and Splicing 3
- RNA modifications and cancer 1
- Co-authors
- Stéphane Heymans (16 shared papers)Blanche Schroen (11 shared papers)Rick van Leeuwen (7 shared papers)Paolo Carai (11 shared papers)Melissa Swinnen (4 shared papers)Geert C. van Almen (2 shared papers)Jack P.M. Cleutjens (2 shared papers)Mark W.M. Schellings (1 shared paper)
- Journals
- European Heart Journal (3 papers)Cardiovascular Research (3 papers)Hypertension (1 paper)Aging Cell (1 paper)Critical Care Medicine (1 paper)
- Partner nations
- NetherlandsBelgiumGermany
In The Last Decade
Wouter Verhesen
16 papers receiving 879 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 377
- Cardiology and Cardiovascular Medicine 313
- Molecular Biology 485
- Aging 10
- Immunology 80
Countries citing papers authored by Wouter Verhesen
This map shows the geographic impact of Wouter Verhesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Verhesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Verhesen more than expected).
Fields of papers citing papers by Wouter Verhesen
This network shows the impact of papers produced by Wouter Verhesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Verhesen. The network helps show where Wouter Verhesen may publish in the future.
Co-authors
The 25 scholars most cited alongside Wouter Verhesen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 213 | |
| 2 | 2012 | 170 | |
| 3 | 2017 | 138 | |
| 4 | 2015 | 95 | |
| 5 | 2012 | 57 | |
| 6 | 2011 | 41 | |
| 7 | 2018 | 38 | |
| 8 | 2017 | 36 | |
| 9 | 2016 | 29 | |
| 10 | 2018 | 26 | |
| 11 | 2018 | 23 | |
| 12 | 2015 | 12 | |
| 13 | First record of Phylloptychoceras (Ammonoidea) from the Maastrichtian type area, The Netherlands | 2006 | 6 |
| 14 | Absence of microRNA-155 protects against adverse cardiac inflammation and hypertrophy during pressure overload and prevents heart failure | 2012 | 2 |
| 15 | Micro-RNA 146a: a new kid on the block in the pathophysiology of cardiac hypertrophy and hypertensive heart failure, and a promising therapeutic target | 2012 | 1 |
| 16 | 2013 | 1 | |
| 17 | Osteoglycin increases cardiac inflammation by enhancing toll-like receptor 4 activation | 2015 | 0 |
| 18 | 2013 | 0 |
About Wouter Verhesen
Wouter Verhesen is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Cancer Research, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 888 indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (4 papers), MicroRNA in disease regulation (3 papers), RNA Research and Splicing (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Paleontology and Stratigraphy of Fossils (1 paper), Cancer-related molecular mechanisms research (1 paper), RNA modifications and cancer (1 paper) and Osteoarthritis Treatment and Mechanisms (1 paper). The work is most often cited by research in Cancer Research (377 citations), Cardiology and Cardiovascular Medicine (313 citations), Molecular Biology (485 citations), Aging (10 citations) and Immunology (80 citations). Wouter Verhesen has collaborated with scholars based in Netherlands, Belgium and Germany. Frequent co-authors include Stéphane Heymans, Blanche Schroen, Rick van Leeuwen, Paolo Carai, Melissa Swinnen, Geert C. van Almen, Jack P.M. Cleutjens, Mark W.M. Schellings, Rick E.W. van Leeuwen and Casper Eurlings. Their work appears in journals such as European Heart Journal, Cardiovascular Research, Hypertension, Aging Cell and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.